Loading...

Syndax Pharmaceuticals, Inc. Peer Comparison

Metric Value Ranking
Market Cap $1.3 Billion 10/19 KRTX
$12.6B
PCVX
$10.6B
RVMD
$7.6B
CYTK
$5.0B
MRUS
$2.8B
EWTX
$2.4B
DICE
$2.3B
DYN
$1.4B
VRDN
$1.4B
SNDX
$1.3B
REPL
$1.0B
COGT
$899.2M
KROS
$413.2M
LRMR
$206.1M
PLRX
$165.5M
STRO
$132.8M
INZY
$86.7M
MRSN
$80.3M
AVTE
$70.7M
Gross Margin 100% 1/19 SNDX
100%
CYTK
100%
MRSN
100%
MRUS
100%
STRO
100%
KROS
100%
VRDN
100%
DYN
0%
COGT
0%
KRTX
0%
REPL
0%
RVMD
0%
LRMR
0%
PLRX
0%
PCVX
0%
INZY
0%
EWTX
0%
AVTE
0%
DICE
0%
Profit Margin -100% 14/19 DYN
0%
COGT
0%
KRTX
0%
REPL
0%
RVMD
0%
LRMR
0%
PLRX
0%
PCVX
0%
INZY
0%
EWTX
0%
AVTE
0%
DICE
0%
MRSN
-91%
SNDX
-100%
CYTK
-100%
MRUS
-100%
STRO
-100%
KROS
-100%
VRDN
-100%
EBITDA margin -717% 14/19 MRSN
-77%
DYN
-100%
COGT
-100%
KRTX
-100%
REPL
-100%
RVMD
-100%
LRMR
-100%
PLRX
-100%
PCVX
-100%
INZY
-100%
EWTX
-100%
AVTE
-100%
DICE
-100%
SNDX
-717%
STRO
-797%
MRUS
-823%
KROS
-15118%
CYTK
-29859%
VRDN
-97070%
Quarterly Revenue $12.5 Million 2/19 MRSN
$12.6M
SNDX
$12.5M
MRUS
$11.8M
STRO
$8.5M
CYTK
$463,000
KROS
$388,000
VRDN
$86,000
DYN
$0
COGT
$0
KRTX
$0
REPL
$0
RVMD
$0
LRMR
$0
PLRX
$0
PCVX
$0
INZY
$0
EWTX
$0
AVTE
$0
DICE
$0
Quarterly Earnings -$84.1 Million 13/19 MRSN
-$11.5M
LRMR
-$15.5M
AVTE
-$16.2M
INZY
-$24.6M
EWTX
-$34.1M
DICE
-$34.8M
STRO
-$48.8M
KROS
-$53.0M
REPL
-$53.1M
PLRX
-$57.8M
COGT
-$70.6M
VRDN
-$76.7M
SNDX
-$84.1M
DYN
-$97.1M
MRUS
-$99.9M
PCVX
-$103.1M
KRTX
-$113.8M
RVMD
-$156.3M
CYTK
-$160.5M
Quarterly Free Cash Flow -$62.3 Million 12/19 MRSN
-$8.6M
AVTE
-$16.0M
PCVX
-$21.7M
INZY
-$24.5M
LRMR
-$24.6M
EWTX
-$27.9M
DICE
-$30.4M
KROS
-$30.9M
PLRX
-$33.2M
REPL
-$40.7M
COGT
-$52.3M
SNDX
-$62.3M
STRO
-$65.3M
VRDN
-$68.0M
DYN
-$74.9M
MRUS
-$80.7M
CYTK
-$104.0M
KRTX
-$111.9M
RVMD
-$133.9M
Trailing 4 Quarters Revenue $16.5 Million 4/19 STRO
$161.0M
MRUS
$35.9M
MRSN
$34.8M
SNDX
$16.5M
PLRX
$4.8M
DYN
$3.8M
CYTK
$3.2M
KRTX
$654,000
KROS
$651,000
VRDN
$302,000
COGT
$0
REPL
$0
RVMD
$0
LRMR
$0
PCVX
$0
INZY
$0
EWTX
$0
AVTE
$0
DICE
$0
Trailing 4 Quarters Earnings -$302.0 Million 15/19 MRSN
$12.6M
SNDX
$12.5M
MRUS
$11.8M
STRO
$8.5M
CYTK
$463,000
KROS
$388,000
VRDN
$86,000
DYN
-$0
COGT
-$0
KRTX
-$0
REPL
-$0
RVMD
-$0
LRMR
-$0
PLRX
-$0
PCVX
-$0
INZY
-$0
EWTX
-$0
AVTE
-$0
DICE
-$0
Quarterly Earnings Growth -64% 17/19 MRSN
72%
AVTE
17%
REPL
12%
RVMD
9%
STRO
1%
PCVX
-11%
CYTK
-24%
COGT
-28%
EWTX
-33%
KROS
-34%
PLRX
-39%
INZY
-48%
KRTX
-49%
DYN
-61%
VRDN
-61%
DICE
-62%
SNDX
-64%
LRMR
-71%
MRUS
-334%
Annual Earnings Growth -63% 16/19 MRSN
64%
STRO
25%
REPL
-2%
AVTE
-10%
CYTK
-12%
DYN
-16%
RVMD
-16%
KROS
-19%
VRDN
-21%
DICE
-26%
PLRX
-28%
COGT
-29%
KRTX
-37%
EWTX
-38%
INZY
-52%
SNDX
-63%
PCVX
-71%
LRMR
-90%
MRUS
-105%
Quarterly Revenue Growth 0% 6/19 KROS
4750%
MRSN
64%
CYTK
22%
VRDN
19%
MRUS
7%
SNDX
0%
DYN
0%
COGT
0%
REPL
0%
LRMR
0%
PLRX
0%
PCVX
0%
INZY
0%
EWTX
0%
AVTE
0%
DICE
0%
STRO
-50%
KRTX
-100%
RVMD
-100%
Annual Revenue Growth 0% 6/19 KROS
8038%
PLRX
551%
STRO
234%
CYTK
8%
VRDN
5%
SNDX
0%
DYN
0%
COGT
0%
REPL
0%
LRMR
0%
PCVX
0%
INZY
0%
EWTX
0%
AVTE
0%
DICE
0%
MRSN
-12%
MRUS
-15%
KRTX
-88%
RVMD
-100%
Cash On Hand $133.0 Million 9/19 PCVX
$1.1B
DYN
$532.2M
KROS
$530.7M
MRUS
$433.0M
RVMD
$201.3M
VRDN
$200.3M
KRTX
$185.8M
STRO
$174.6M
SNDX
$133.0M
REPL
$113.5M
COGT
$97.0M
PLRX
$79.6M
MRSN
$78.9M
DICE
$73.5M
CYTK
$46.9M
EWTX
$44.8M
LRMR
$35.1M
AVTE
$31.1M
INZY
$24.6M
Short Term Debt $852,000 16/19 CYTK
$30.4M
MRSN
$19.0M
PCVX
$9.6M
RVMD
$8.4M
STRO
$7.2M
DYN
$4.8M
INZY
$4.6M
REPL
$4.0M
KRTX
$2.8M
KROS
$1.9M
MRUS
$1.8M
DICE
$1.5M
COGT
$1.5M
LRMR
$1.0M
EWTX
$992,000
SNDX
$852,000
AVTE
$459,000
PLRX
$322,000
VRDN
-$0
Long Term Debt $0 18/19 CYTK
$759.3M
RVMD
$78.3M
REPL
$72.2M
PLRX
$59.9M
INZY
$42.2M
VRDN
$20.5M
DYN
$20.0M
MRSN
$18.6M
PCVX
$18.3M
STRO
$17.7M
KROS
$17.4M
COGT
$16.3M
KRTX
$13.8M
DICE
$11.0M
LRMR
$4.3M
EWTX
$3.4M
AVTE
$81,000
SNDX
$0
MRUS
$0
PE -1.00 1/19 SNDX
-1.00
DYN
-1.00
COGT
-1.00
CYTK
-1.00
MRSN
-1.00
MRUS
-1.00
KRTX
-1.00
REPL
-1.00
STRO
-1.00
RVMD
-1.00
KROS
-1.00
LRMR
-1.00
PLRX
-1.00
PCVX
-1.00
INZY
-1.00
EWTX
-1.00
VRDN
-1.00
AVTE
-1.00
DICE
-1.00
PS 76.71 6/19 KRTX
19264.95
VRDN
4684.57
CYTK
1546.39
KROS
634.68
DYN
373.97
SNDX
76.71
MRUS
76.71
PLRX
34.20
MRSN
2.30
STRO
0.82
COGT
-1.00
REPL
-1.00
RVMD
-1.00
LRMR
-1.00
PCVX
-1.00
INZY
-1.00
EWTX
-1.00
AVTE
-1.00
DICE
-1.00
PB 3.46 7/19 MRSN
76.55
KRTX
10.05
EWTX
5.01
RVMD
4.83
DICE
4.37
MRUS
3.92
SNDX
3.46
PCVX
3.12
COGT
2.86
REPL
2.72
DYN
2.01
VRDN
2.00
STRO
1.19
INZY
1.05
LRMR
1.04
AVTE
0.88
KROS
0.78
PLRX
0.48
CYTK
0.00
PC 9.54 7/19 CYTK
106.16
KRTX
67.80
EWTX
54.63
RVMD
37.56
DICE
30.91
PCVX
10.14
SNDX
9.54
COGT
9.27
REPL
9.15
VRDN
7.06
MRUS
6.37
LRMR
5.88
INZY
3.53
DYN
2.66
AVTE
2.27
PLRX
2.08
MRSN
1.02
KROS
0.78
STRO
0.76
Liabilities to Equity 0.16 8/19 MRSN
160.61
STRO
3.06
INZY
0.73
REPL
0.31
PLRX
0.29
COGT
0.22
MRUS
0.20
SNDX
0.16
RVMD
0.13
AVTE
0.13
LRMR
0.10
DYN
0.09
KROS
0.09
VRDN
0.09
KRTX
0.07
DICE
0.06
EWTX
0.05
PCVX
0.04
CYTK
0.00
ROA -0.71 18/19 PCVX
-14%
DICE
-18%
EWTX
-24%
STRO
-27%
MRUS
-29%
LRMR
-30%
RVMD
-31%
KROS
-31%
KRTX
-32%
VRDN
-33%
DYN
-39%
CYTK
-40%
MRSN
-43%
REPL
-43%
PLRX
-47%
COGT
-63%
INZY
-67%
SNDX
-71%
AVTE
-93%
ROE -0.82 15/19 CYTK
4143%
PCVX
-15%
DICE
-19%
EWTX
-25%
LRMR
-33%
KRTX
-34%
RVMD
-34%
KROS
-34%
MRUS
-35%
VRDN
-36%
DYN
-42%
REPL
-56%
PLRX
-61%
COGT
-77%
SNDX
-82%
AVTE
-105%
STRO
-111%
INZY
-117%
MRSN
-7020%
Current Ratio 7.17 11/19 PCVX
25.05
EWTX
22.82
DICE
17.42
KRTX
16.30
KROS
12.47
DYN
12.15
VRDN
11.99
LRMR
10.62
RVMD
8.96
AVTE
8.69
SNDX
7.17
MRUS
5.97
COGT
5.54
PLRX
4.46
REPL
4.27
INZY
2.37
STRO
1.33
MRSN
1.01
CYTK
0.99
Quick Ratio 6.56 11/19 SNDX
-1.00
DYN
-1.00
COGT
-1.00
CYTK
-1.00
MRSN
-1.00
MRUS
-1.00
KRTX
-1.00
REPL
-1.00
STRO
-1.00
RVMD
-1.00
KROS
-1.00
LRMR
-1.00
PLRX
-1.00
PCVX
-1.00
INZY
-1.00
EWTX
-1.00
VRDN
-1.00
AVTE
-1.00
DICE
-1.00
Long Term Debt to Equity 0.00 16/19 MRSN}
17.72
INZY}
0.51
REPL}
0.19
PLRX}
0.17
STRO}
0.16
COGT}
0.05
RVMD}
0.05
DYN}
0.03
KROS}
0.03
VRDN}
0.03
LRMR}
0.02
DICE}
0.02
KRTX}
0.01
PCVX}
0.01
EWTX}
0.01
SNDX}
0.00
MRUS}
0.00
AVTE}
0.00
CYTK}
-54.58
Debt to Equity 0.00 17/19 MRSN
30.03
INZY
0.57
STRO
0.22
REPL
0.20
PLRX
0.17
COGT
0.06
RVMD
0.06
DYN
0.04
KROS
0.04
LRMR
0.03
VRDN
0.03
DICE
0.02
KRTX
0.01
PCVX
0.01
EWTX
0.01
AVTE
0.01
SNDX
0.00
MRUS
0.00
CYTK
-48.51
Burn Rate 1.58 13/19 PCVX
9.88
KROS
9.81
DYN
5.37
MRSN
4.64
MRUS
4.32
STRO
3.40
VRDN
2.58
LRMR
2.20
DICE
2.06
REPL
1.99
AVTE
1.90
KRTX
1.61
SNDX
1.58
COGT
1.35
PLRX
1.32
EWTX
1.30
RVMD
1.25
INZY
0.90
CYTK
0.24
Cash to Cap 0.10 13/19 STRO
1.32
KROS
1.28
MRSN
0.98
PLRX
0.48
AVTE
0.44
DYN
0.38
INZY
0.28
LRMR
0.17
MRUS
0.16
VRDN
0.14
COGT
0.11
REPL
0.11
SNDX
0.10
PCVX
0.10
RVMD
0.03
DICE
0.03
EWTX
0.02
CYTK
0.01
KRTX
0.01
CCR 0.74 14/19 LRMR
1.59
STRO
1.34
INZY
1.00
AVTE
0.99
KRTX
0.98
VRDN
0.89
DICE
0.87
RVMD
0.86
EWTX
0.82
MRUS
0.81
DYN
0.77
REPL
0.77
MRSN
0.75
SNDX
0.74
COGT
0.74
CYTK
0.65
KROS
0.58
PLRX
0.57
PCVX
0.21
EV to EBITDA -12.68 15/19 KROS}
1.67
STRO}
0.25
COGT}
-1.00
REPL}
-1.00
RVMD}
-1.00
LRMR}
-1.00
PCVX}
-1.00
INZY}
-1.00
EWTX}
-1.00
AVTE}
-1.00
DICE}
-1.00
PLRX}
-2.36
MRSN}
-3.40
DYN}
-8.64
SNDX}
-12.68
VRDN}
-14.79
MRUS}
-23.99
CYTK}
-40.55
KRTX}
-96.25
EV to Revenue 68.71 5/19 KRTX
19006.33
VRDN
4089.22
CYTK
1741.48
DYN
240.04
SNDX
68.71
MRUS
64.71
PLRX
30.19
MRSN
0.95
STRO
-0.11
COGT
-1.00
REPL
-1.00
RVMD
-1.00
LRMR
-1.00
PCVX
-1.00
INZY
-1.00
EWTX
-1.00
AVTE
-1.00
DICE
-1.00
KROS
-150.88